← Leaderboards
Miranda Wallace
Washington University
$241,732
Attributed
$241,732
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $120.9K · FY2024–25$200K$150K$100K$50K$0
'24
'25
Funding mix
By agency
NIH$241,732 · 1
By mechanism
K99$241,732 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Timothy E Holy$21,059,469
- Megan T Baldridge$11,493,915
- Gautam Dantas$16,547,812
- Eduardo A. Groisman$21,000,681
- Thaddeus S Stappenbeck$13,810,421
Others in their field
Other Rising Stars on “Alternative Therapies”
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
- Hsin-Jung Yang · Cedars-Sinai Medical Center$3,123,890
- David T. Kent · Vanderbilt University Medical Center$3,120,041
- Bozena Korczak · Vascular Vision Pharmaceuticals Company$3,058,782
Research focus
Alternative TherapiesAntibiotic ResistanceAntibioticsAntibiotic TherapyAntibody MimeticsAnti-Infective AgentsAntimicrobialAnti-Microbial PeptideBacteriaBacteriophagesBacteroides FragilisBile AcidsBindingBinding ProteinsBiological AvailabilityBuilt EnvironmentClinically SignificantClostridium DifficileCollectionCombatCombinatorialCommensal MicrobesConventional TherapyAerobic
Grant awards (2)
Expanding the therapeutic capacity of Saccharomyces cerevisiae var. boulardii for the treatment of gastrointestinal infections$120,866
K99 · FY2025 · AT · contact PI
Expanding the therapeutic capacity of Saccharomyces cerevisiae var. boulardii for the treatment of gastrointestinal infections$120,866
K99 · FY2024 · AT · contact PI